ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #2,936Top JournalHybrid

International Immunopharmacology

Acronym:intimp
•
Abbreviation (ISO):Int. Immunopharmacol
•
Identifier (ISSN):1567-5769(Print)/1878-1705(Online)
•
Publisher:Elsevier
Clarivate IF (2026)
5.6↑ +0.9
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for International Immunopharmacology

WoS Q1
24683.1220183.3620193.9420204.9320215.7120225.620234.820244.720255.62026
Annual Impact Factor Metric
Current (2026):5.6
Scopus SJR & RankScopus Q1
1.354
#2,936

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
165

165 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate4.2%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
1,023articles/year
22.16% Gold OA•93.98% Original Research

Aims & Scope

International Immunopharmacology is the primary vehicle for the publication of original research papers pertinent to the overlapping areas of immunology, pharmacology, cytokine biology, immunotherapy, immunopathology and immunotoxicology. Review articles that encompass these subjects are also welcome. The subject material appropriate for submission includes: • Clinical studies employing immunotherapy of any type including the use of: bacterial and chemical agents; thymic hormones, interferon, lymphokines, etc., in transplantation and diseases such as cancer, immunodeficiency, chronic infection and allergic, inflammatory or autoimmune disorders. • Studies on the mechanisms of action of these agents for specific parameters of immune competence as well as the overall clinical state. • Pre-clinical animal studies and in vitro studies on mechanisms of action with immunopotentiators, immunomodulators, immunoadjuvants and other pharmacological agents active on cells participating in immune or allergic responses. • Pharmacological compounds, microbial products and toxicological agents that affect the lymphoid system, and their mechanisms of action. • Agents that activate genes or modify transcription and translation within the immune response. • Substances activated, generated, or released through immunologic or related pathways that are pharmacologically active. • Production, function and regulation of cytokines and their receptors. • Classical pharmacological studies on the effects of chemokines and bioactive factors released during immunological reactions.

Topics Covered (Recognized by AI)
Medicine97.2%Biology96.6%Internal medicine89.1%Genetics88.9%Chemistry84.2%Immunology83.9%Biochemistry80.9%Endocrinology48.3%Immune system42.6%Pharmacology40.1%Inflammation38.9%Cell biology38.6%Pathology38.5%Gene32.8%Organic chemistry31.1%Receptor29.4%In vitro27.6%Physics25.5%Signal transduction22%Apoptosis21.3%Cancer research20.6%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

IMMUNOLOGY

Q1
Rank42/183
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank55/356
IndexSCIE
JCISCIE2026

IMMUNOLOGY

Q1
Rank32/183
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank48/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF5.6
Articles / Year1,206
Total Citations620
2025
IF4.7
Articles / Year1,963
Total Citations9,365
2024
IF4.8
Articles / Year2,291
Total Citations23,179
2023
IF5.6
Articles / Year1,673
Total Citations25,968
2022
IF5.714
Articles / Year1,054
Total Citations23,339

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #2,936Scopus Q1SCImago Profile
Scopus Coverage:2001-2026
Scopus Broad Areas:Immunology and MicrobiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.354

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.64

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,434 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations26,719
3-Year Documents4,625
Citable Documents4,596

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)4

Citations in government and international policy documents

Female Author Rate44.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Immunology and AllergyQ1
PharmacologyQ1
ImmunologyQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 4.2%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区IMMUNOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

International Immunopharmacology (acronym: intimp, abbr: Int. Immunopharmacol, ISSN: 1567-5769) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier in Netherlands since 2001. The periodical holds a Journal Impact Factor (JIF) of 5.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.354 (Q1), an H-index of 165.

The journal enforces rigorous peer evaluation with an average review speed of 7.5周, a publication frequency of Monthly, an annual output of approximately 1,023 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,434 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Elsevier
Publication Language
English
Frequency
Monthly
Founding Year
2001
Indexing & Databases
SCIEScopusPubMed
Editorial Address
ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: eb5975df-a47c-4494-89f7-3e5018a2ab46
Database Updated: 2026-10-16